Share
Market Research Report

TYPHOID FEVER VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Vaccine TypeLive Attenuated Vaccine · Capsular Polysaccharide Vaccines · Conjugate Vaccine · Others
  • By Route of AdministrationOral · Parenteral
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In19 Feb 2026
  • Report CodeCMI2552
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Vaccine Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • PEST Analysis
    • Awareness Strategy
    • Reimbursement Scenario
    • Typhoid Fever Vaccines Shortage
    • Clinical Trial Analysis
    • Countries with High Number of Incidents of Snake Bites
    • Market Entry Challenges
  4. Global Typhoid Fever Vaccines Market, By Vaccine Type, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Live Attenuated Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Capsular Polysaccharide Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Conjugate Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
  5. Global Typhoid Fever Vaccines Market, By Route of Administration, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
    • Parental
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
  6. Global Typhoid Fever Vaccines Market, By Region, 2026 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2026–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
      • GlaxoSmithKline Plc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sanofi SA
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bharat Biotech
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Med Pvt. Ltd.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • PT Bio Farma
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • PaxVax, Inc.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Shanghai Institute of Biological Products Co., Ltd.
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Prokarium
        • Company Introduction
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section

    • References
    • Research Methodology
    • About Us and Sales Contact